Home » Newsletters » BioWorld

BioWorld

March 31, 1994

View Archived Issues

GEN-PROBE TEST CLEARED FOR RELEASE

AUTOIMMUNE'S MS DRUG ENTERS PHASE III TRIALS

ALLELIX COMPLETES PHASE I TRIAL

APPOINTMENTS AND ADVANCEMENTS

ACTISITE CLEARED FOR MARKETING

CEL-SCI ENDS TALKS

BORON BIOLOGICALS GETS NIH GRANT FOR STUDY

AMGEN TO COLLABORATE WITH MIT

GENSET, SALK RECONCILE OVERLAPPING PATENTS

ONCOTRAC MOVES CLOSER TO MARKETING APPROVAL

MILLENNIUM, ROCHE FINALIZE $70M PACT

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...